Company: CI
Filing Date: 2025-03-14
Form Type: DEF 14A
Source: 0001739940-25-000015
Chunk: 12

Company: Cigna Group
Filing Date: 2025-03-14
Form: DEF 14A
Chunk 12
---
 |

We have a deep and long-held commitment to strong governance as well as ethical and resilient business practices. This includes protecting the sensitive data of our clients and customers by ensuring cybersecurity incident response preparedness, as well as supporting a responsible and inclusive supply chain. Priority topics include: • Leadership and Accountability • Business Ethics and Compliance • Data Protection • Responsible Supply Chain

| The Cigna Group| 2025 Notice of Annual Meeting of Shareholders and Proxy Statement |     | 9 |

| PROXY STATEMENT SUMMARY |

#### Voting Matters and Board Recommendations
| For the reasons set forth below and as further detailed throughout this Proxy Statement, the Board of Directors unanimously recommends that you voteFOReach of the management proposals. |

| Management Proposals |     |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  |     | More Information |
|                      |     | Proposal 1. Election of Directors.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               
 The Board and the Corporate Governance Committee believe that the eleven director nominees named in this Proxy Statement bring a combination of diverse qualifications, skills, and experiences that contribute to a well-functioning Board. As determined by the Board and Corporate Governance Committee, each director nominee has proven leadership ability, has demonstrated good judgment, and is a valued participant on the Board.                                                                                                       |     | Page12           |
|                      |     | Proposal 2. Advisory Approval of Executive Compensation.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         
 Our executive compensation program is designed to base the substantial majority of our executive officers’ compensation on The Cigna Group performance, rewarding them for the creation of long-term value benefiting our customers, patients, clients, shareholders and other stakeholders. Because your vote is advisory, it will not be binding upon the Board. However, the Board and the People Resources Committee value your opinion and will review and consider the voting results when making future executive compensation decisions. |     | Page51           |
|                      |     | Proposal 3. Ratification of the Appointment of PricewaterhouseCoopers LLP as our Independent Registered Public Accounting Firm for 2025.                                                                                                                                                                                                                                                                                                                                                                                                         
 The Audit Committee approved the appointment of PricewaterhouseCoopers LLP as the independent registered public accounting firm for The Cigna Group for 2025. The Audit Committee and the Board believe that the continued retention of PricewaterhouseCoopers LLP to serve as the Company’s independent registered public accounting firm is in the best interests of the Company and its shareholders. As a matter of good corporate governance, the Board is seeking shareholder ratification of the appointment.                             |     |